TOM1

gene product
This gene was identified as a target of the v-myb oncogene. The encoded protein shares its N-terminal domain in common with proteins associated with vesicular trafficking at the endosome. It is recruited to the endosomes by its interaction with endofin. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
178 antibodies from 23 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Abnova Corporation
8 antibodies
LifeSpan BioSciences, Inc.
29 antibodies
antibodies-online
56 antibodies
Novus Biologicals
8 antibodies
Biorbyt
10 antibodies
NovoPro Bioscience Inc.
7 antibodies
Abgent
5 antibodies
Atlas Antibodies
2 antibodies
Invitrogen Antibodies
4 antibodies
Bethyl Laboratories
2 antibodies
St John's Laboratory
1 antibody
Proteintech Group
2 antibodies
Aviva Systems Biology
3 antibodies
OriGene
2 antibodies
Creative Biolabs
6 antibodies
RabMAbs
3 antibodies
Creative Diagnostics
3 antibodies
GeneTex
2 antibodies
Boster Biological Technology
1 antibody
United States Biological
20 antibodies
Sigma-Aldrich
2 antibodies
MyBioSource
1 antibody
RayBiotech, Inc.
1 antibody